46
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics and Prognoses of Mucormycosis in Four Children

ORCID Icon, &
Pages 1971-1978 | Received 18 Mar 2024, Accepted 11 May 2024, Published online: 18 May 2024

References

  • Elitzur S, Fischer S, Arad-Cohen N, et al. Disseminated Mucormycosis in Immunocompromised Children: are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study. J Fungi. 2021;7(3):165. doi:10.3390/jof7030165
  • Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34. doi:10.1093/cid/cir866
  • Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi. 2019;5.
  • Francis JR, Villanueva P, Bryant P, Blyth CC. Mucormycosis in Children: review and Recommendations for Management. J Pediatric Infectious Dis Society. 2018;7(2):159–164. doi:10.1093/jpids/pix107
  • Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infection. 2011;17(12):1859–1867. doi:10.1111/j.1469-0691.2010.03456.x
  • Pagano L, Valentini C, Posteraro B, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21(3):322–329. doi:10.1179/joc.2009.21.3.322
  • Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infectious Dis. 2012;54 Suppl 1:S35–43. doi:10.1093/cid/cir880
  • Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infection. 2019;25(1):26–34. doi:10.1016/j.cmi.2018.07.011
  • Park B, Pappas P, Wannemuehler K, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Em Infect Dis. 2011;17(10):1855–1864. doi:10.3201/eid1710.110087
  • Pagano L, Offidani M, Fianchi L, et al. Mucormycosis in hematologic patients. Haematologica. 2004;89(2):207–214.
  • Roilides E, Zaoutis TE, Walsh TJ. Invasive zygomycosis in neonates and children. Clin Microbiol Infect. 2009;15:50–54. doi:10.1111/j.1469-0691.2009.02981.x
  • Danion F, Coste A, Le Hyaric C, et al. What Is New in Pulmonary Mucormycosis? J Fungi. 2023;9(3). doi:10.3390/jof9030307
  • Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis-The bitter and the sweet. PLoS Pathog. 2017;13:e1006408. doi:10.1371/journal.ppat.1006408
  • Rangwala S, Strickland B, Rennert R, et al. Ruptured Mycotic Aneurysm of the Distal Circulation in a Patient with Mucormycosis Without Direct Skull Base Extension. Case Report. 2019;16:E101–E107.
  • Ermak D, Kanekar S, Specht CS, Wojnar M, Lowden M. Looks like a Stroke, Acts like a Stroke, but It’s More than a Stroke: a Case of Cerebral Mucormycosis. J Stroke Cerebrovascular Dis. 2014;23(8):e403–e404. doi:10.1016/j.jstrokecerebrovasdis.2014.02.024
  • Economopoulos N, Kelekis D, Papadopoulos A, Kontopoulou C, Brountzos EN. Subclavian Artery Occlusion and Pseudoaneurysm Caused by Lung Apex Mucormycosis: successful Treatment with Transcatheter Embolization. CardioVascular Interventional Radiol. 2006;30:143–145. doi:10.1007/s00270-005-0328-1
  • Nevitt P, Das Narla L, EJPr H. Mucormycosis resulting in a pseudoaneurysm in the spleen. Pediatric Radiol. 2001;31(2):115–116. doi:10.1007/s002470000383
  • Trinh K, Le D, Callahan T. Endovascular management of a pulmonary artery pseudoaneurysm secondary to mucormycosis: a case report. Radiol Case Rep. 2023;18(11):4214–4217. doi:10.1016/j.radcr.2023.08.116
  • Alvernia J, Patel R, Cai D, Dang N, Anderson D, Melgar MJN. A successful combined endovascular and surgical treatment of a cranial base mucormycosis with an associated internal carotid artery pseudoaneurysm. Neurosurgery. 2009;65(4):733–740. doi:10.1227/01.NEU.0000351773.74034.5E
  • Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos GJ. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(suppl_1):93–101. doi:10.1093/mmy/myx101
  • Zhang J, Luo J, Weng X, et al. A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia. Ann Transl Med. 2022;10(12):722. doi:10.21037/atm-22-2533
  • Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP. Therapy of Mucormycosis. J Fungi. 2018;4.
  • Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405–e421. doi:10.1016/S1473-3099(19)30312-3
  • Smith C, Lee SC. Current treatments against mucormycosis and future directions. PLoS Pathog. 2022;18(10):e1010858. doi:10.1371/journal.ppat.1010858
  • Pruthi H, Muthu V, Bhujade H, et al. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: case Series and Systematic Review of the Literature. Mycopathologia. 2022;187(1):31–37. doi:10.1007/s11046-021-00610-9